ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,149.78
0.16%
Dow Jones
42,938.51
-0.89%
Gold vs US Dollar
2,619.90
-0.49%
Brent Oil
73.785
1.23%
Bitcoin
94,336.85
-1.41%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. (MM) (PCYC)

  7. (MM) (PCYC) News

(MM) (PCYC)

(MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCYC
DateTimeSourceHeadlineSymbolCompany
15/06/201519:02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PCYC(MM)
10/06/201516:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCYC(MM)
05/06/201511:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PCYC(MM)
01/06/201515:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PCYC(MM)
31/05/201513:05PR Newswire (US)Ibrutinib (IMBRUVICA®) Phase Ib/II Data Show Promise in Patients with Chronic Graft-Versus-Host-DiseaseNASDAQ:PCYC(MM)
30/05/201511:31PR Newswire (US)Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Surv...NASDAQ:PCYC(MM)
28/05/201523:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201522:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201513:00PR Newswire (US)Ibrutinib (IMBRUVICA®) in Combination with Anti-PD-L1 Antibody (MEDI4736) Study Commences for Patients with Two Relapsed/Ref...NASDAQ:PCYC(MM)
26/05/201512:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCYC(MM)
26/05/201512:48Edgar (US Regulatory)(25-NSE)NASDAQ:PCYC(MM)
26/05/201512:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PCYC(MM)
26/05/201511:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:30Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201511:25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
 Showing the most relevant articles for your search:NASDAQ:PCYC

Your Recent History

LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
UPS
LSE
GEX
Georgina Energy
LSE
TRP
Tower Resources
LSE
MIN
Minoan
LSE
DEC
Diversified Energy
LSE
GDR
Genedrive
LSE
BIRD
Blackbird
LSE
VTY
Vistry
LSE
SRT
Srt Marine Systems
LSE
RPI
Raspberry Pi
LSE
SRSP
Sirius Petroleum
LSE
BARC
Barclays
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads